-
Authors :
Shodai A; Department of Hematology and Rheumatology, Kagoshima University Hospital.; Tazaki Y
Subjects: Tyrosine Kinase Inhibitors* ; Leukemia, Myelogenous, Chronic, BCR-ABL Positive*/Leukemia, Myelogenous, Chronic, BCR-ABL Positive*/Leukemia, Myelogenous, Chronic, BCR-ABL Positive*/drug therapy ; Leukemia, Myelogenous, Chronic, BCR-ABL Positive*/Leukemia, Myelogenous, Chronic, BCR-ABL Positive*/Leukemia, Myelogenous, Chronic, BCR-ABL Positive*/genetics
-
Source:
[Rinsho ketsueki] The Japanese journal of clinical hematology [Rinsho Ketsueki] 2023; Vol. 64 (2), pp. 102-106.Publisher: Japan Society Of Clinical Hematology Country of Publication: Japan NLM ID: 2984782R Publication Model: Print Cited Medium: Print ISSN:
Record details